These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2550860)

  • 1. Resistance to antiviral drugs at last.
    N Z Med J; 1989 Sep; 102(875):487. PubMed ID: 2550860
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.
    Erice A; Chou S; Biron KK; Stanat SC; Balfour HH; Jordan MC
    N Engl J Med; 1989 Feb; 320(5):289-93. PubMed ID: 2536135
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to antiviral drugs: the end of innocence.
    Hirsch MS; Schooley RT
    N Engl J Med; 1989 Feb; 320(5):313-4. PubMed ID: 2536138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.
    Cole NL; Balfour HH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):255-61. PubMed ID: 3032503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.
    Michel D; Höhn S; Haller T; Jun D; Mertens T
    J Med Virol; 2001 Sep; 65(1):70-6. PubMed ID: 11505446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 8. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the interaction of interferon with anti-herpetic agents].
    Naito T
    Nippon Ganka Gakkai Zasshi; 1988 Jul; 92(7):1177-84. PubMed ID: 2847515
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
    Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ganciclovir [9-(1,3-dihydroxy-2-propoxymethyl)] guanine. A new antiviral agent against Cytomegalovirus].
    Petersen CS; Skinhøj P
    Ugeskr Laeger; 1989 Aug; 151(34):2156-8. PubMed ID: 2773153
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.
    Plotkin SA; Drew WL; Felsenstein D; Hirsch MS
    J Infect Dis; 1985 Oct; 152(4):833-4. PubMed ID: 2995505
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient.
    Baldanti F; Simoncini L; Talarico CL; Sarasini A; Biron KK; Gerna G
    AIDS; 1998 May; 12(7):816-8. PubMed ID: 9619816
    [No Abstract]   [Full Text] [Related]  

  • 14. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of drugs based on native DNA against RNA and DNA containing viruses].
    Vaĭnberg IP; Nosik DN; Kaplina EN; Nosik NN; Kalnina LB; Lavrukhina LA
    Klin Med (Mosk); 1995; 73(6):3-5. PubMed ID: 8691775
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the cytotoxicity of a new anti-herpetic agent, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, on the rabbit cornea].
    Naito T; Shiota H; Kanematsu S; Mimura Y; Ogawa T
    Nippon Ganka Gakkai Zasshi; 1988 Apr; 92(4):573-7. PubMed ID: 2841833
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance in cytomegalovirus: current knowledge and implications for patient management.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 12 Suppl 1():S1-22. PubMed ID: 8680897
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
    Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
    J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate.
    Biron KK; Fyfe JA; Stanat SC; Leslie LK; Sorrell JB; Lambe CU; Coen DM
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8769-73. PubMed ID: 3022304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir-resistant cytomegalovirus in organ transplant recipients.
    Limaye AP
    Clin Infect Dis; 2002 Oct; 35(7):866-72. PubMed ID: 12228824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.